COMMEMORATIVE LECTURE Structural Insights Into the Functions of the Large Ribosomal Subunit, a Major Antibiotic Target Thomas A

Total Page:16

File Type:pdf, Size:1020Kb

COMMEMORATIVE LECTURE Structural Insights Into the Functions of the Large Ribosomal Subunit, a Major Antibiotic Target Thomas A COMMEMORATIVE LECTURE Structural Insights into the Functions of the Large Ribosomal Subunit, a Major Antibiotic Target Thomas A. Steitz Investigator, Howard Hughes Medical Institute and Sterling Professor of Molecular Biophysics and Biochemistry, Yale University Professor of Chemistry, Yale University, New Haven, CT, USA (Received for publication on Ausust 25, 2007) Key words: Ribosome structure, RNA, antibiotics, protein synthesis, ribozyme Chairman (Prof. Yoshikazu Nakamura, Institute for Prof. Thomas A. Steitz, Department of Molecular Medical Science, University of Tokyo): Finally we will Biophysics and Biochemistry and Department of have a lecture by Prof. Thomas A. Steitz. He is the win- Chemistry, Yale University, and Howard Hughes ner of Keio Medical Science Prize. Already, he explained Medical Institute: It is a great pleasure to be here, and or talked about his personal history and therefore really I thank you so much for that kind introduction. As I said do not need to repeat the same thing; but briefly I would yesterday, it is always wonderful to come to Japan and like to introduce his career. He graduated in Chemistry visit. My son and I had a great breakfast this morning; a from Lawrence College,Wisconsin in 1962, and he fin- sushi breakfast at the fish dock,*1 the best sushi that I ished his PhD in biochemistry and molecular biology at ever had in my life; it is going to be hard to do this again, Harvard University. Then he started his professional ca- I have to say, back home. My son is out having a good reer path in Harvard University, the same department of time in Tokyo and I am here having to talk, so I am go- chemistry, and he also spent three years 1967-1970 in ing to have a good time too. Cambridge, England, where he met so many important I would like to start out by giving an introduction to the figures as we learned yesterday. Then he got an appoint- ribosome and the ribosome problem, and then provide a ment in Yale University in molecular biophysics and bio- few details about how we solved the structure of the chemistry in 1970. Since then he has stayed in the same large ribosomal subunit. Now, I realize that this is an un- department, and carried up through an assistant profes- specialized audience with respect to structure determina- sorship, associate professorship and full professorship. tion, with one or two exceptions obviously here, but I He has received quite many awards. Among those just I want to give a sense of what the problem was that needed will mention a few important points. In 1990, he became to be solved and how we went about it, but that will only a member of the National Academy of Sciences in the be five slides, so not to worry. Then I shall talk about United States, and also the same year a member of the what we have done to understand the mechanism of pep- American Academy of Arts and Sciences. He received tide bond formation. Finally, I shall talk about the antibi- several awards: for example, in the year 2001, the Rosen- otic binding studies that we have done and the examina- stein Award for Distinguished Work in Basic Medical tion of the effect of resistance mutations, and finally talk Science, and the latest one in the year 2004, the Frank about what Rib-X Pharmaceuticals, Inc.―the company Westheimer Medal of Harvard University. As you know, that I and some of my colleagues started five years ago this year he received the Keio Medical Science Prize. He ―are doing to use this information to design new antibi- received it; I trust and I hope that this award is the best otics, which looks like it is going to be successful. and prestigious award. Now we will ask Tom for this lec- I shall start with a fact published in Nature a couple of ture about “Structural insights into the functions of the years ago, that in the United States, two million people large ribosomal subunit, a major antibiotic target.” will acquire antibiotic resistance infections in US hospi- tals, and 90,000 will die of it. Indeed, this is a significant Dr. Steitz is the recepient of the 2006 Keio Medical Science Prize. Presented at the Keio Medical Science Prize Symposium, November 2, 2006. Reprint requests to: Dr. Tomas A. Steitz 266 Whitney Avenue, Bass 418 P.O. Box 208114 New Haven, CT USA 06520 – 8114 *1 A fish dock at Tsukiji in Tokyo. 1 2 Steitz TA : structures of the large ribosomal subunit problem. Another important point is that the ribosome is another 1,500 in the small subunits; so the whole assem- a major target of antibiotics―in fact, the major target― bly of the 70S is about two and a half million molecular and the large ribosomal subunit is the major target in weight, two-thirds RNA by mass. Think of it as an RNA protein synthesis. Consequently, our understanding of machine contaminated with proteins, whereas the spli- how a large ribosomal subunit works and how it is inhib- ceosome, I tell my wife,*2 is a protein machine contami- ited by antibiotics should indeed to be helpful to attack- nated with RNA. The ribosomes constitute one-fourth of ing this problem. the bacterial cell mass, so it is very abundant, and of But let me back up and say a few things about our ap- course that is extremely useful if you want to do struc- proach. There are some differences of opinions about tural studies, to have a very abundant machine. how one should do structural biology. This is my opin- Now the early structural work in the mid-70’s was ion, which was exhibited very well by Dr. Yokoyama a done by Jim Lake using negative staining in electron mi- couple of lectures ago. That is: you need to have the croscopy, and he was able only to show the shapes of the structures of every stage of a process in order to under- two subunits, but his shapes for the individual subunits stand that process. It is not just good enough to have one are largely right at this resolution of 50 Å or so; then ex- structure; you need to have them all. So it certainly is not amining the model of the whole ribosome you can see enough to look at the pieces. As you know, most assem- that the two subunits are sort of snuggling up here like a blies are made from a lot of pieces. It is easy for us to be pair with the small subunit lying on top of the large sub- reductionists; we all reductionists, and we are tempted to unit. Using cryo-electron microscopy (cryo-EM), it was look at whatever we can get our hands on, but knowing possible to go to somewhat higher resolution by 1997 the structures of the pieces of a clock does not tell you and position these transfer RNA (tRNA) molecules ap- how a clock works. But I might say that even if you proximately correctly, showing the CCA going into the know the structure of a clock sitting there, that does not large subunit and the anticodon loops of decoding a fic- tell you how a clock works either. So what you have to tionally placed messenger RNA, and then the E-site do is have the structures of the clock or the assembly that tRNA, and more or less over here but again not exactly works at each step in that process. Even though some of positioned correctly. So that is where we were in our un- the steps are metastable, you have to be a clever bio- derstanding of ribosome structures approximately 10 chemist and figure out how to stabilize that state so you years ago. can take a snapshot of it, and then you can put it together I have met up with Venki Ramakrishnan many times― into a movie. So that is the philosophy that we have tak- actually, he was a post-doc at Yale in the 1980s with Don en with all the problems that we were studying in the lab. Engleman and Peter Moore―but I met him in Sweden at I did show some movies yesterday, and that is how we a meeting, so we had a photo opportunity, and I am go- are looking at the ribosome as well. ing to use Venki’s structure of the small ribosomal sub- We have been looking at all aspects of gene expression, unit and put it together with our structure of the larger ri- but of course today I am just going to focus on the ribo- bosomal subunit to get the structure of the whole 70S ri- some and indeed I am only going to focus on the large ri- bosome. The two subunits were positioned using the co- bosomal subunit where peptide bond formation occurs. ordinates of the phosphate backbone of the 70S from This schematic drawing of protein synthesis by Jim Wat- Harry Noller and his three A-site, P-site, E-site tRNAs. sonshows where our understanding of the ribosome was Venki, as you may have noticed if you are paying atten- in 1964. It was known that the decoding happens in the tion to this area, has recently determined at 2.8 ang- small subunit and peptide bond formation occurs on the stroms resolution the structure of the 70S assembly with large subunit. Also shown was the A site, where the ami- tRNAs bound in the P site and E site and partially the A noacyl-tRNA binds, and the P site, where the peptidyl- site (5); so there is an even more accurate structure of tRNA binds, which he proposed existed, but he did not this assembly than shown in Figure 1 but I think for our know about the E site, where the exiting deacylated present purpose you would not be able to tell the differ- tRNA binds, and he did not know about the polypeptide ence, nor would I.
Recommended publications
  • How a Chemist Looks at RNA Thomas R
    Angewandte Chemie DOI: 10.1002/anie.201205427 RNA Chemistry How a Chemist Looks at RNA Thomas R. Cech* 1989 chemical genetics · kinetics · RNA · thermo- dynamics I was passing through customs some time ago, returning from splicing reaction.[5] At the same time, it became increasingly London. The immigration officer, seemingly unsatisfied with clear that rRNA must have an active role in protein syn- my self-identification as “professor,” inquired about my thesis,[6] which was later confirmed in atomic detail by X-ray research area. “Molecular biology,” I answered; then added crystallography.[7] Evolution-in-a-test-tube experiments “ribonucleic acid,” certain this would convince him that I was showed that the potential versatility of RNA far exceeded harmless. the examples found in nature thus far,[8] adding credibility to At other times I identify myself as a biochemist, but the idea of a primordial “RNA World” where RNA served as almost never as just-plain chemist. This may seem a bit odd, both genetic material and as catalyst. given that all of my formal degrees (B.A. Grinnell College, The next rush of RNA discoveries concerned RNA as Ph.D. UC Berkeley) are in Chemistry, my first (and only) a regulator of gene expression. It had previously been thought faculty appointment has been in a Department of Chemistry, that most regulation was conducted by proteins that either and I teach General Chemistry to undergraduates. The repressed or activated gene transcription (the DNA!RNA opportunity to write something to help celebrate 125 years step) or regulated mRNA stability or translation (the RNA! of Angewandte Chemie has prompted me to organize some protein step).
    [Show full text]
  • Dashawn Hickman
    DaShawn Antwane Hickman 2816 Edgehill Road |Cleveland Heights, OH 44118 Phone: (203) 873-8344 |Email: [email protected] Education Case Western Reserve University, Cleveland, OH Doctor of Philosophy (Ph.D) expected May 2017 Doctor of Medicine (M.D.) expected May 2019 Yale University, New Haven, CT Bachelor of Science, Biomedical Engineering Awarded May 2009 A.C. Flora High School, Columbia, SC High School Diploma Awarded May 2005 International Baccalaureate Diploma Awarded May 2005 Research Department of Biomedical Engineering, Case Western Reserve University, Graduate Student Experience Cleveland, OH, May 2013-August 2015 § Principle Investigator: Erin Lavik, ScD § Synthesize polymer based hemostatic nanoparticles § Characterize nanoparticles using dynamic light scattering and ultra performance liquid chromatography § Validate efficacy and safety of treatments in rodent and porcine animal models § Investigate the immune response (CARPA) to hemostatic nanoparticles Department of Internal Medicine/Gastroenterology and Hepatology, University of Arkansas for Medical Sciences, Research Technician Little Rock, AR, Feb 2011-May 2011 § Principle Investigator: Jonathan Dranoff, MD § Perform functional and molecular studies on bile duct epithelia and portal fibroblast § Develop models examining the interaction of bile duct epithelia and portal fibroblast § Independent Literature Review § Present research in formal lab meetings Department of Internal Medicine/Digestive Diseases, Yale University, Postgraduate Associate New Haven, CT, July
    [Show full text]
  • Yale University New Faculty Orientation Handbook Contents
    Yale University New Faculty Orientation Handbook Contents 3 New Faculty Orientation Agenda 7 Welcome to Yale 9 New Faculty Orientation Participants 12 New Faculty Biographies & Headshots 32 Get the Facts! 41 Titles IV Policies at Yale 78 Teaching at Yale: An Introduction to the Yale Center for Teaching and Learning 91 Understanding Review, Promotion and Leaves 132 Yale Faculty Handbook: Full Document 134 Research & Teaching Resources: Concurrent Sessions 135 Session A: Using Yale Library Resources in Your Research & Teaching 138 Session B: Managing Grants, Contracts, & External Funding at Yale 167 Session C: Using Yale’s Collections in your Research & Teaching 176 Session D: Teaching, Learning and Research with Technology 179 Session E: Environmental Health & Safety in your Lab/Research 190 Office of Post Doctorial Affairs 193 TEAL Classroom Yale University New Faculty Orientation Agenda 2014-2015 New Faculty Member Orientation Academic Year 2014 – 15 Tuesday, August 19th 5:30 pm Welcome BBQ with Provost (New Faculty & Guests, Deans, and Chairs invited) 35 Hillhouse Avenue Ben Polak Provost of Yale University; William C. Brainard Professor of Economics and Management Wednesday, August 20th 8:00 am Registration and Breakfast Presidents Room, 2nd Floor of Memorial Hall 8:30 am Introductions & Overview of Agenda James Antony Associate Provost 8:45 am Welcome to Yale Peter Salovey President of Yale University; Chris Argyris Professor of Psychology 9:00 am Undergraduate and Graduate Students at Yale: An Overview Presidents Room, 2nd Floor,
    [Show full text]
  • Fifth–Year Report
    Fifth-Year Interim Report to the New England Association of Schools and Colleges Commission on Institutions of Higher Education Yale University New Haven, Connecticut August 15, 2014 Table of Contents Introduction . 1 Institutional Overview . 1 Responses to Areas Identified for Special Emphasis . 3 1. Financial Resources . 4 2. The West Campus . 6 3. Graduate Student Facilities & Campus Life . 9 4. Leadership and Faculty Diversity . 10 5. Assessment . .14 6. Committee on Yale College Education Follow-Up . 14 Standards: Changes since 2009 and Future Projections 1. Mission and Purpose . 15 2. Planning and Evaluation . 16 3. Organization and Governance . 20 4. The Academic Program. 22 5. Faculty. 28 6. Students . 30 7. Library and Information Resources . 32 8. Physical and Technological Resources . 35 9. Financial Resources . 37 10. Public Disclosure . 39 11. Integrity . 41 Assessment, Retention, and Student Success . 43 Plans for the Future. 59 INTRODUCTION Yale University’s 2014 Fifth-Year NEASC Interim Report offers the opportunity not only to reflect on changes since the 2009 Self Study, but also to consider the future. We address the six areas identified for special emphasis by the Commission on Institutions of Higher Education, discussing actions taken and making projections about what needs continued attention. We review the eleven CIHE Standards, reporting on significant changes since our 2009 evaluation as well as how Yale continues to meet the standards and projects future directions. In Standard Four, The Academic Program, we focus on the Faculty of Arts and Sciences, which teaches over two-thirds of Yale students and has the largest contingent of Yale faculty.
    [Show full text]
  • University Science Strategy Committee
    University Science Strategy Committee Scott Strobel, PhD (Chair) Scott Strobel joined the Yale faculty in 1995 in the Department of Molecular Biophysics & Biochemistry (MB&B) where he served as department chair from 2006-09 and currently holds the Henry Ford II Professorship. Since 2011 he has served as vice president for West Campus planning & program development, and in July 2014 he took on additional responsibility as the inaugural deputy provost for teaching & learning. In this capacity, he will oversee the development of a comprehensive Yale Center for Teaching and Learning that will promote teaching excellence, foster improved student learning, and provide a clear pathway for teaching resources and support to Yale faculty, postdocs, graduate students, and undergraduate students. In 2006 and again in 2010, he was named a Howard Hughes Medical Institute (HHMI) Professor to promote efforts in undergraduate science education. With this award he instituted a program to explore microbial and chemical diversity in the world’s rainforests as a means to inspire undergraduate students in the sciences. He was awarded the Dylan Hixon Prize for Teaching Excellence in the Natural Sciences in 2004 and the Graduate Mentoring Award in the Sciences in 2007. He received his B.A. from Brigham Young University and his Ph.D. from the California Institute of Technology. His current research explores the chemical basis of RNA function and catalysis and hydrocarbon production by endophytic fungi. Daniel Alfonso Colón-Ramos, PhD Daniel Colón-Ramos was born and raised in Puerto Rico. He completed his B.A. at Harvard University, his PhD in the lab of Dr.
    [Show full text]
  • Structural Insights Into Peptide Bond Formation
    Structural insights into peptide bond formation Jeffrey L. Hansen*, T. Martin Schmeing*, Peter B. Moore*†, and Thomas A. Steitz*†‡§ Departments of *Molecular Biophysics and Biochemistry and †Chemistry, Yale University and ‡Howard Hughes Medical Institute, 266 Whitney Avenue, New Haven, CT 06520-8114 Contributed by Thomas A. Steitz, July 8, 2002 The large ribosomal subunit catalyzes peptide bond formation and under conditions where the chemical step of peptide bond will do so by using small aminoacyl- and peptidyl-RNA fragments formation is likely to be rate limiting, demonstrate the existence of tRNA. We have refined at 3-Å resolution the structures of both of a titratable ribosomal component that affects catalysis and has A and P site substrate and product analogues, as well as an a pKa of 7.4 (18). Its effects disappear when A2486 (2451) is intermediate analogue, bound to the Haloarcula marismortui 50S mutated to U, and the rate of peptide bond formation catalyzed ribosomal subunit. A P site substrate, CCA-Phe-caproic acid–biotin, by the A2486U mutant ribosome is reduced by greater than binds equally to both sites, but in the presence of sparsomycin 100-fold (18). These results could be explained either if A2486 binds only to the P site. The CCA portions of these analogues are (2451) acts as a general base or if there is an unknown pH- bound identically by either the A or P loop of the 23S rRNA. sensitive conformational change in the ribosome that depends on Combining the separate P and A site substrate complexes into one A2486 (2451).
    [Show full text]
  • Yale-NECHE 2019 Report 09.20.19
    YALE UNIVERSITY 2019 SELF-STUDY Report to the New England Commission of Higher Education Submitted September 2019 Table of Contents University Leadership and Organization ......................................................................................... i Table of NECHE Actions, Items of Special Attention, or Concerns ............................................. iv Introduction and Institutional Overview ......................................................................................... v Standard 1: Mission and Purposes .................................................................................................. 1 Standard 2: Planning and Evaluation .............................................................................................. 6 Standard 3: Organization and Governance ................................................................................... 14 Standard 4: The Academic Program ............................................................................................. 21 Standard 5: Students ..................................................................................................................... 34 Standard 6: Teaching, Learning, and Scholarship ........................................................................ 55 Standard 7: Institutional Resources .............................................................................................. 70 Standard 8: Educational Effectiveness.........................................................................................
    [Show full text]
  • Nobel Lecture by Thomas A. Steitz
    FROM THE STRUCTURE AND FUNCTION OF THE RIBOSOME TO NEW ANTIBIOTICS Nobel Lecture, December 8, 2009 by THOMAS A. STEITZ Department of Molecular Biophysics and Biochemistry, Department of Chemistry, Yale University and the Howard Hughes Medical Institute, 266 Whitney Avenue, New Haven, CT 06520-8114, USA. My passion for pursuing structural studies of biological macromolecules in order to understand how they carry out their functions was initiated by a Dunham lecture that Max Perutz presented at Harvard Medical School in the spring of 1963, a year after he shared the Nobel Prize in Chemistry with John Kendrew for determining the frst protein structures. He showed a very large audience the frst stereo slide of an atomic structure of a protein, myoglobin, that any of us had ever seen. When the myoglobin structure popped into three dimensions over his head, a loud “oh” came from the audience. I knew then how I wanted to understand the chemistry of biology. I began my thesis research at Harvard by working with a team in the laboratory of William N. Lipscomb, a Nobel chemistry Laureate in 1976, on the structure of carboxypeptidase A. I did postdoctoral studies with David Blow at the MRC lab of Molecular Biology in Cambridge studying chymotrypsin. My interactions with Jim Watson and with Wally Gilbert while I was at Harvard and the numerous contacts that I had with Francis Crick and Sydney Brenner while I was at Cambridge stimulated my three decade long interest in obtaining the structural basis of Crick’s Central Dogma: “DNA makes DNA makes RNA makes Protein”.
    [Show full text]
  • Gift Launches Yale Autoimmunity Center
    november/december 2019 volume 15, issue 3 Advancing Biomedical Science, Education, and Health Care Yale School of Medicine prepares to welcome its 19th dean Yale College alumna Nancy medicine and fellowship in clinical Brown has been chair of pharmacology at Vanderbilt, she joined the faculty there in 1992. medicine at Vanderbilt The path to leadership that Brown followed at Vanderbilt reflects Nancy J. Brown, MD, has been her passions for pursuing research appointed the next dean of Yale and nurturing the next generation School of Medicine (YSM), effec- of physician-scientists. She was chief tive February 1, 2020. of the Division of Clinical Pharma- Brown, who is in line to be the cology, which is part of both a basic 19th dean of the medical school science department (pharmacology) and first woman to hold the post, and a clinical department (medicine). joins Yale from Vanderbilt Uni- She served as associate dean for versity School of Medicine, where clinical and translational scientist she is Hugh J. Morgan Professor development, establishing the Elliot and chair of the Department of Newman Society to support the devel- Medicine. A 1981 alumna of Yale opment of physician-scientists, before College, where she majored in becoming chair of medicine in 2010. robert a. lisak molecular biophysics and biochem- She also co-founded the Vanderbilt Under her stewardship, Vander- Nancy Brown takes office as dean on February 1. istry, Brown earned her medical Master of Science in Clinical Investi- bilt’s Department of Medicine, Her early priorities include improving the work climate at the School of Medicine, exploring new degree at Harvard University.
    [Show full text]
  • Metal-Binding Sites in the Major Groove of a Large Ribozyme Domain Jamie H Cate and Jennifer a Doudna*
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE Researchprovided Article by Elsevier1221 - Publisher Connector Metal-binding sites in the major groove of a large ribozyme domain Jamie H Cate and Jennifer A Doudna* Background: Group I self-splicing introns catalyze sequential Address: Deptartment of Molecular Biophysics transesterification reactions within an RNA transcript to produce the correctly and Biochemistry, Yale University, New Haven, CT spliced product. Often several hundred nucleotides in size, these ribozymes fold 06520, USA. into specific three-dimensional structures that confer activity. The 2.8 Å crystal *Corresponding author. structure of a central component of the Tetrahymena thermophila group I intron, E-mail: [email protected] the 160-nucleotide P4–P6 domain, provides the first detailed view of metal Key words: binding in an RNA large enough to exhibit side-by-side helical packing. The group I intron, MAD phasing, osmium hexammine, RNA long-range contacts and bound ligands that stabilize this fold can now be examined in detail. Received: 5 August 1996 Revisions requested: 29 August 1996 Results: Heavy-atom derivatives used for the structure determination reveal Revisions received: 5 September 1996 Accepted: 5 September 1996 characteristics of some of the metal-binding sites in the P4–P6 domain. Although long-range RNA–RNA contacts within the molecule primarily involve Structure 15 October 1996, 4:1221–1229 the minor groove, osmium hexammine binds at three locations in the major groove. All three sites involve G and U nucleotides exclusively; two are formed by © Current Biology Ltd ISSN 0969-2126 G⋅U wobble base pairs.
    [Show full text]
  • Abstract Booklet Wout Participants
    DISCUSSION MEETING ON The chemical origins of life and its early evolution Monday 21 and Tuesday 22 February 2011 Organised by Professor David Lilley FRS and Professor John Sutherland Programme and abstracts Speaker biographies Participant list Notes Publication order form The abstracts which follow are provided by the presenters and the Royal Society takes no responsibility for their content. 1 The chemical origins of life and its early evolution Monday 21 – Tuesday 22 February 2011 Organised by Professor David Lilley FRS, University of Dundee and Professor John Sutherland, MRC Laboratory of Molecular Biology, Cambridge DAY 1 DAY 2 SESSION 1 SESSION 2 SESSION 3 SESSION 4 Prebiotic chemistry: setting the stage Self-assembled vesicles The RNA world: RNA catalysis Emerging from the RNA world Chair: Professor John Sutherland Chair: Professor Fritz Eckstein Chair: Professor David Lilley FRS Chair: Dr Venki Ramakrishnan FRS 09.00 Welcome by Stephen Cox Royal Society Executive Director 09.05 Introduction by David Lilley Jack Szostak Hiroaki Suga 13.30 An optimal degree of chemical 09.00 Scott Strobel 13.30 09.20 Norm Sleep The RNA origin of transfer RNA heterogeneity for the origin of Ribozymes and riboswitches Serpentinite and the dawn of Life aminoacylation and beyond life? 09.50 Discussion 14.00 Discussion 09.30 Discussion 14.00 Discussion Mike Yarus John Sutherland Aminoacylation, transacylation Paul Schimmel 10.00 14.15 09.45 Sidney Altman 14.15 RNA – prebiotic product, or biotic and peptide synthesis facilitated Mistranslation and its
    [Show full text]
  • Molecular Biophysics and Biochemistry 1 Molecular Biophysics and Biochemistry
    Molecular Biophysics and Biochemistry 1 Molecular Biophysics and Biochemistry 336 Bass Center, 203.432.5662 https://mbb.yale.edu M.S., M.Phil., Ph.D. Chair Enrique De La Cruz Director of Graduate Studies Karla Neugebauer (SHM C123, 203.785.3322, [email protected]) Graduate Registrar Meghan Killoran (Bass 336, 203.432.5662, [email protected]) Professors Karen Anderson (Pharmacology), Susan Baserga, Ronald Breaker (Molecular, Cellular, & Developmental Biology), Gary Brudvig (Chemistry), Sandy Chang (Laboratory Medicine), Enrique De La Cruz, Daniel DiMaio (Genetics; Therapeutic Radiology), Donald Engelman, Alan Garen (Emeritus), Mark Gerstein, Nigel Grindley (Emeritus), Sharon Hammes-Schiffer (Chemistry), Mark Hochstrasser, Jonathon Howard, Michael Koelle, Anthony Koleske, William Konigsberg, J. Patrick Loria (Chemistry), I. George Miller (Pediatric Infectious Diseases; Public Health), Andrew Miranker, Peter Moore (Emeritus; Chemistry), Karla Neugebauer, Karin Reinisch (Cell Biology), David Schatz (Immunobiology), Robert Shulman (Emeritus), Fred Sigworth (Cellular & Molecular Physiology; Biomedical Engineering), Dieter Söll, Mark Solomon, Joan Steitz, Scott Strobel, Kenneth Williams (Adjunct; Research), Yong Xiong, Carl Zimmer (Adjunct) Associate Professors Julien Berro, Titus Boggon (Pharmacology), Wendy Gilbert, Erdem Karatekin (Cellular & Molecular Physiology), Christian Schlieker, Matthew Simon, Seyedtaghi Takyar (Internal Medicine/Pulmonary), Yongli Zhang (Cell Biology) Assistant Professors Franziska Bleichert, Lilian
    [Show full text]